Michelle Donachie

Papers

2

Total Citations

346

H-Index

2

About

Michelle Donachie is a leading clinical researcher in urologic oncology, with a focused expertise in the surgical management of bladder cancer. Her work is pivotal in the ongoing debate between robot-assisted and open surgical techniques. She is best known for her landmark 2022 study, cited over 320 times, which rigorously compared robot-assisted radical cystectomy with intracorporeal urinary diversion to the traditional open approach. This high-impact trial provided critical evidence on 90-day morbidity and mortality, directly informing surgical decision-making for patients with bladder cancer. Building on this, Donachie has also advanced the conversation by evaluating the cost-effectiveness of these procedures, demonstrating a commitment to both clinical outcomes and healthcare economics. Her research is instrumental in defining the value and recovery benefits of minimally invasive surgery, making her a key voice in shaping modern urological practice and guiding surgeons toward evidence-based, patient-centered care.

Research Focus

Key Achievements

2
H-Index
2
Papers
346
Total Citations
173
Avg Citations/Paper
🏆 Most Cited Paper
Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer
320 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 70

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago